Mochida Pharmaceutical Co., Ltd. (4534.T)
JPY 3090.0
(0.16%)
JPY 3090.0
(0.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 52.07 Billion JPY | -5.52% |
| 2022 | 55.11 Billion JPY | -7.45% |
| 2021 | 59.55 Billion JPY | 8.69% |
| 2020 | 54.79 Billion JPY | 5.53% |
| 2019 | 51.91 Billion JPY | -4.16% |
| 2018 | 54.17 Billion JPY | 1.14% |
| 2017 | 53.56 Billion JPY | -4.87% |
| 2016 | 56.31 Billion JPY | 2.38% |
| 2015 | 55 Billion JPY | 3.1% |
| 2014 | 53.34 Billion JPY | -10.47% |
| 2013 | 59.58 Billion JPY | 5.59% |
| 2012 | 56.43 Billion JPY | 0.14% |
| 2011 | 56.35 Billion JPY | 15.12% |
| 2010 | 48.95 Billion JPY | -1.0% |
| 2009 | 49.44 Billion JPY | 5.94% |
| 2008 | 46.67 Billion JPY | 0.92% |
| 2007 | 46.25 Billion JPY | 2.82% |
| 2006 | 44.98 Billion JPY | 2.61% |
| 2005 | 43.83 Billion JPY | 7.68% |
| 2004 | 40.71 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 12.95 Billion JPY | 10.48% |
| 2024 Q2 | 12.32 Billion JPY | -4.84% |
| 2023 FY | 52.07 Billion JPY | -5.52% |
| 2023 Q4 | 11.72 Billion JPY | -20.91% |
| 2023 Q3 | 14.82 Billion JPY | 20.45% |
| 2023 Q1 | 13.2 Billion JPY | 20.68% |
| 2023 Q2 | 12.31 Billion JPY | -6.78% |
| 2022 Q1 | 15.25 Billion JPY | 19.92% |
| 2022 Q4 | 10.94 Billion JPY | -30.5% |
| 2022 Q3 | 15.74 Billion JPY | 19.54% |
| 2022 Q2 | 13.17 Billion JPY | -13.68% |
| 2022 FY | 55.11 Billion JPY | -7.45% |
| 2021 Q4 | 12.72 Billion JPY | -28.91% |
| 2021 Q1 | 14.95 Billion JPY | 26.19% |
| 2021 FY | 59.55 Billion JPY | 8.69% |
| 2021 Q2 | 13.97 Billion JPY | -6.57% |
| 2021 Q3 | 17.89 Billion JPY | 28.09% |
| 2020 Q2 | 12.73 Billion JPY | -11.57% |
| 2020 FY | 54.79 Billion JPY | 5.53% |
| 2020 Q1 | 14.39 Billion JPY | 29.73% |
| 2020 Q4 | 11.85 Billion JPY | -25.03% |
| 2020 Q3 | 15.8 Billion JPY | 24.15% |
| 2019 Q2 | 12.45 Billion JPY | -11.87% |
| 2019 Q1 | 14.13 Billion JPY | 26.12% |
| 2019 FY | 51.91 Billion JPY | -4.16% |
| 2019 Q4 | 11.09 Billion JPY | -22.0% |
| 2019 Q3 | 14.22 Billion JPY | 14.22% |
| 2018 FY | 54.17 Billion JPY | 1.14% |
| 2018 Q2 | 12.61 Billion JPY | -19.67% |
| 2018 Q3 | 14.65 Billion JPY | 16.23% |
| 2018 Q4 | 11.2 Billion JPY | -23.54% |
| 2018 Q1 | 15.69 Billion JPY | 52.62% |
| 2017 Q4 | 10.28 Billion JPY | -32.69% |
| 2017 Q3 | 15.28 Billion JPY | 23.53% |
| 2017 Q1 | 15.62 Billion JPY | 33.5% |
| 2017 FY | 53.56 Billion JPY | -4.87% |
| 2017 Q2 | 12.37 Billion JPY | -20.84% |
| 2016 Q2 | 13.13 Billion JPY | -12.52% |
| 2016 Q4 | 11.7 Billion JPY | -28.88% |
| 2016 Q3 | 16.46 Billion JPY | 25.34% |
| 2016 FY | 56.31 Billion JPY | 2.38% |
| 2016 Q1 | 15.01 Billion JPY | 26.38% |
| 2015 FY | 55 Billion JPY | 3.1% |
| 2015 Q4 | 11.87 Billion JPY | -25.49% |
| 2015 Q3 | 15.94 Billion JPY | 18.98% |
| 2015 Q2 | 13.39 Billion JPY | -2.8% |
| 2015 Q1 | 13.78 Billion JPY | 12.95% |
| 2014 Q2 | 13.57 Billion JPY | 7.06% |
| 2014 Q3 | 14.89 Billion JPY | 9.7% |
| 2014 Q4 | 12.2 Billion JPY | -18.04% |
| 2014 FY | 53.34 Billion JPY | -10.47% |
| 2014 Q1 | 12.67 Billion JPY | -10.57% |
| 2013 Q1 | 14.21 Billion JPY | 10.14% |
| 2013 Q3 | 16.67 Billion JPY | 14.8% |
| 2013 Q4 | 14.17 Billion JPY | -14.98% |
| 2013 FY | 59.58 Billion JPY | 5.59% |
| 2013 Q2 | 14.52 Billion JPY | 2.2% |
| 2012 FY | 56.43 Billion JPY | 0.14% |
| 2012 Q3 | 15.76 Billion JPY | 11.36% |
| 2012 Q4 | 12.9 Billion JPY | -18.13% |
| 2012 Q1 | 13.61 Billion JPY | 18.66% |
| 2012 Q2 | 14.15 Billion JPY | 3.97% |
| 2011 Q1 | 11.98 Billion JPY | 2.81% |
| 2011 Q2 | 15.86 Billion JPY | 32.35% |
| 2011 Q4 | 11.47 Billion JPY | -32.65% |
| 2011 FY | 56.35 Billion JPY | 15.12% |
| 2011 Q3 | 17.03 Billion JPY | 7.37% |
| 2010 Q2 | 11.97 Billion JPY | -1.38% |
| 2010 Q1 | 12.14 Billion JPY | 15.77% |
| 2010 Q3 | 13.17 Billion JPY | 9.99% |
| 2010 Q4 | 11.65 Billion JPY | -11.5% |
| 2010 FY | 48.95 Billion JPY | -1.0% |
| 2009 Q2 | 12.45 Billion JPY | 0.4% |
| 2009 Q4 | 10.49 Billion JPY | -25.63% |
| 2009 Q3 | 14.1 Billion JPY | 13.3% |
| 2009 Q1 | 12.4 Billion JPY | 17.88% |
| 2009 FY | 49.44 Billion JPY | 5.94% |
| 2008 Q4 | 10.52 Billion JPY | -19.42% |
| 2008 Q2 | 11.66 Billion JPY | 0.0% |
| 2008 FY | 46.67 Billion JPY | 0.92% |
| 2008 Q3 | 13.05 Billion JPY | 11.96% |
| 2007 FY | 46.25 Billion JPY | 2.82% |
| 2006 FY | 44.98 Billion JPY | 2.61% |
| 2005 FY | 43.83 Billion JPY | 7.68% |
| 2004 FY | 40.71 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | -6.806% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 97.617% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 72.3% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 85.892% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -1370.552% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 46.329% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | -36.23% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 91.121% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -768.123% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 34.064% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -285.219% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -572.913% |
| Tsumura & Co. | 68.81 Billion JPY | 24.336% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | -39.445% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | -110.027% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 36.019% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | -215.289% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | -3.764% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | -1.304% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -4725.765% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -429.22% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -1080.454% |
| MedRx Co., Ltd | 26 Million JPY | -200169.231% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -548.789% |
| Solasia Pharma K.K. | 337 Million JPY | -15351.039% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 7123219.015% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | -69.803% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 4.14% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -137855.702% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 53.914% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -684.234% |